Systems analysis of the response of photosynthesis, metabolism, and growth to an increase in irradiance in the photosynthetic model organism Chlamydomonas reinhardtii T Mettler, T Mühlhaus, D Hemme, MA Schöttler, J Rupprecht, A Idoine, ... The Plant Cell 26 (6), 2310-2350, 2014 | 137 | 2014 |
The mitochondrial alternative oxidase from Chlamydomonas reinhardtii enables survival in high light Y Kaye, W Huang, S Clowez, S Saroussi, A Idoine, E Sanz-Luque, ... Journal of Biological Chemistry 294 (4), 1380-1395, 2019 | 43 | 2019 |
Zanubrutinib versus ibrutinib in relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma: interim analysis of a randomized phase III trial P Hillmen, B Eichhorst, JR Brown, N Lamanna, SM O'Brien, CS Tam, ... Journal of Clinical Oncology 41 (5), 1035, 2023 | 35 | 2023 |
Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study M Shadman, IW Flinn, MY Levy, RF Porter, JM Burke, SF Zafar, J Misleh, ... The Lancet Haematology 10 (1), e35-e45, 2023 | 35 | 2023 |
Construction of a shuttle vector using an endogenous plasmid from the cyanobacterium Synechocystis sp. PCC6803 H Jin, Y Wang, D Bhaya Frontiers in microbiology 9, 345780, 2018 | 35 | 2018 |
The diurnal logic of the expression of the chloroplast genome in Chlamydomonas reinhardtii AD Idoine, A Boulouis, J Rupprecht, R Bock PLoS One 9 (10), e108760, 2014 | 27 | 2014 |
The HIV-1 Pr55gag polyprotein binds to plastidial membranes and leads to severe impairment of chloroplast biogenesis and seedling lethality in transplastomic … N Scotti, L Sannino, A Idoine, P Hamman, A De Stradis, P Giorio, ... Transgenic Research 24, 319-331, 2015 | 18 | 2015 |
Preliminary results of the phase 2 study of zanubrutinib in patients with previously treated B‐cell malignancies intolerant to ibrutinib and/or acalabrutinib M Shadman, JP Sharman, MY Levy, R Porter, SF Zafar, JM Burke, ... Hematological Oncology 39, 2021 | 9 | 2021 |
Recombination in feline lentiviral genomes during experimental cross-species infection M Poss, A Idoine, HA Ross, JA Terwee, S VandeWoude, A Rodrigo Virology 359 (1), 146-151, 2007 | 9 | 2007 |
Zanubrutinib in acalabrutinib-intolerant patients (pts) with B-cell malignancies M Shadman, IW Flinn, EC Kingsley, B Freeman, MY Levy, H Holmes, ... Blood 140 (Supplement 1), 3655-3657, 2022 | 8 | 2022 |
Acquired Mutations in Patients (Pts) with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) That Progressed in the ALPINE Study JR Brown, J Li, BF Eichhorst, N Lamanna, SM O'Brien, CS Tam, L Qiu, ... Blood 142, 1890, 2023 | 1 | 2023 |
Zanubrutinib in acalabrutinib-intolerant patients (pts) with B-cell malignancies M Shadman, IW Flinn, EC Kingsley, BB Freeman, M Levy, CM Farber, ... Blood 142, 3279, 2023 | 1 | 2023 |
PB1890: zanubrutinib in acalabrutinib-intolerant patients (PTS) with B-cell malignancies M Shadman, IW Flinn, EC Kingsley, B Freeman, MY Levy, J Cultrera, ... HemaSphere 6, 1769-1770, 2022 | 1 | 2022 |
Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib-and/or acalabrutinib-intolerant patients with B-cell malignancies L Xu, M Shadman, IW Flinn, MY Levy, R Porter, JM Burke, SF Zafar, ... Haematologica, 2020 | 1 | 2020 |
OP112 Evaluation Of A Self-Administered Smart Phone-Based Application As A Wellness Measure In A Clinical Trial Of Zanubrutinib R Crescenzo, A Idoine, K Yang International Journal of Technology Assessment in Health Care 39 (S1), S31-S31, 2023 | | 2023 |
Genomic Landscape of Ibrutinib-and/or Acalabrutinib-intolerant Patients with B-cell Malignancies Treated with Zanubrutinib in a Phase 2 Study L Xu, M Shadman, IW Flinn, M Levy, R Porter, JM Burke, SF Zafar, ... Blood 142, 6510, 2023 | | 2023 |
P633: UPDATED SAFETY AND EFFICACY RESULTS OF ZANUBRUTINIB IN PATIENTS WITH B-CELL MALIGNANCIES WHO ARE INTOLERANT OF IBRUTINIB AND/OR ACALABRUTINIB M Shadman, MY Levy, R Porter, JM Burke, JL Cultrera, J Misleh, ... HemaSphere 7 (S3), e70152b3, 2023 | | 2023 |
Zanubrutinib in patients with B-cell malignancies intolerant to ibrutinib and/or acalabrutinib M Shadman, J Sharman, M Levy, R Porter, SF Zafar, JM Burke, ... Leukemia and Lymphoma, S117-S118, 2021 | | 2021 |
Validation of Abiotic Bacterial Surrogates for Surface Sanitation in Food Processing Facilities N Herbold, A Idoine, P Mattei, J Atchley, S Johnson, L Clotilde, Q Chou, ... IAFP 2019 Annual Meeting, 2019 | | 2019 |
Evaluation of Abiotic Bacterial Surrogates for Validation and Verification of One-pass Produce Wash Systems L Clotilde, X Nou, Y Luo, E Wilhelmsen, A Idoine, B Zhou, S Bolten, G Gu, ... IAFP 2019 Annual Meeting, 2019 | | 2019 |